Closing Bell Overtime: Pfizer CEO on Drug Pricing, China’s EV Moves and Evercore's Julian Emanuel on Record Highs 2/18/25

Evercore ISI's Julian Emanuel analyzes the market outlook and what he is telling clients as stocks sit near records. Our Angelica Peebles sits down with Pfizer CEO Albert Bourla to discuss drug pricing and industry challenges as the sector readies itself for HHS RFK Jr. Rockefeller International's Ruchir Sharma weighs in on China’s Xi-CEO meeting. Plus, Morgan sits down with Saronic CEO Dino Mavrookas, talking the company's new capital raise and its shipbuilding efforts while Jon talks with Abridge CEO Dr. Shiv Rao on bringing AI to patient care.